Unexpected Dynamic Binding May Rescue the Binding Affinity of Rivaroxaban in a Mutant of Coagulation Factor X
A novel coagulation factor X (FX) Tyr319Cys mutation (Y99C as chymotrypsin numbering) was identified in a patient with severe bleeding. Unlike the earlier reported Y99A mutant, this mutant can bind and cleave its specific chromogenetic substrate at a normal level, suggesting an intact binding pocket...
Main Authors: | Zhi-Li Zhang, Changming Chen, Si-Ying Qu, Qiulan Ding, Qin Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.877170/full |
Similar Items
-
Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
by: Alexander Kaserer, et al.
Published: (2019-11-01) -
Association between hypocalcemia and rivaroxaban in coagulation disorders: a case report
by: Alexandre Mio Pos, et al.
Published: (2020-01-01) -
Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation
by: Fabienne Lucas, et al.
Published: (2021-10-01) -
Dosing-time-dependent effect of rivaroxaban on coagulation activity in rats
by: Yuki Fujiwara, et al.
Published: (2017-08-01) -
Effects of Rivaroxaban on Coagulation Assays in Patients with Small Pulmonary Embolism and Deep Vein Thrombosis in Relation to Body Mass Index
by: Shima Ghahremani, et al.
Published: (2019-09-01)